BayWa's Restructuring Teeters as Key Asset Sale Fails and Banks Hold the Keys

German agri-trader BayWa's future hinges on banks after a €1.7B deal collapse. It plans 1,300 job cuts, asset sales, and faces a governance crisis.

The fate of German agricultural trading group BayWa is hanging by a thread, with a €2.7 billion hole at the center of its restructuring plan and its future now dependent on the forbearance of two major creditor banks. The collapse of a critical asset sale has left the company scrambling for cash, forcing a severe operational overhaul and leaving investors flying blind without reliable financial data.

At the heart of the crisis is the failed partial sale of the renewable energy subsidiary BayWa r.e., which was expected to raise up to €1.7 billion. The deal fell apart after changes to US subsidy regulations undermined its economic foundation. This failure leaves the company's four-billion-euro restructuring target more than half unfunded. In response, management is pulling the emergency brake, planning to cut approximately 1,300 jobs by the end of 2028.

The company's cooperative owners, the Bavarian Volks- und Raiffeisenbanken, are caught in a double bind as both major shareholders and lenders. Their support measures to date total roughly €550 million, according to association president Stefan Müller. The strain is intensifying; the primary institutions already wrote down €132 million on a promissory note in 2024 and now face the risk of a total loss on these securities. While they maintain their own stability is not at risk, they are being urged to build additional capital buffers.

A small cash injection is expected at the end of April, totaling a three-digit million-euro sum from the sale of the Cefetra business and associated loan repayments. One source specifies the Cefetra portion at €45 million. This money, however, is seen merely as a bargaining chip in tense negotiations with core creditors. The company is also attempting to sell its New Zealand fruit trading subsidiary T&G Global, with Goldman Sachs seeking buyers for an expected €300 million, though a minority shareholder in Hong Kong is reportedly complicating the process.

The ultimate decision rests with main creditors DZ Bank and HVB (HypoVereinsbank). They must agree to extend a standstill agreement until autumn 2026 to provide the legal foundation for the entire restructuring. If they refuse, the plan collapses. The banks are demanding harsh concessions, including debt haircuts, subordination, and a dividend ban.

This profound uncertainty is reflected starkly on the stock market. The share price, quoted at €12.85 in one report and €13.15 in another, is hovering just above its 52-week low and far below its 50-day average of €15.65. Since the start of the year, the stock has plummeted by over 23 percent.

Simultaneously, a governance crisis is eroding oversight. Several supervisory board members are departing this spring with no successors yet named. In reaction to past control deficits, the board has slashed the approval threshold for transactions to just €50 million. In a further blow to transparency, the company fired its auditor PwC after the oversight body Apas initiated professional misconduct proceedings, citing that existential balance sheet risks were declared too late.

Consequently, the audited group financial statements for 2025 are not expected until the fourth quarter of 2026. Management has withdrawn its guidance for the current year entirely. Until a verified report appears, shareholders are navigating without a reliable fundamental data basis, their investment's survival contingent on a bank decision expected this autumn.